184 related articles for article (PubMed ID: 37976368)
21. Comparative cytotoxicity of chelidonine and homochelidonine, the dimethoxy analogues isolated from Chelidonium majus L. (Papaveraceae), against human leukemic and lung carcinoma cells.
Havelek R; Seifrtova M; Kralovec K; Krocova E; Tejkalova V; Novotny I; Cahlikova L; Safratova M; Opletal L; Bilkova Z; Vavrova J; Rezacova M
Phytomedicine; 2016 Mar; 23(3):253-66. PubMed ID: 26969379
[TBL] [Abstract][Full Text] [Related]
22. Loss of the forkhead transcription factor FoxM1 causes centrosome amplification and mitotic catastrophe.
Wonsey DR; Follettie MT
Cancer Res; 2005 Jun; 65(12):5181-9. PubMed ID: 15958562
[TBL] [Abstract][Full Text] [Related]
23. Central spindle proteins and mitotic kinesins are direct transcriptional targets of MuvB, B-MYB and FOXM1 in breast cancer cell lines and are potential targets for therapy.
Wolter P; Hanselmann S; Pattschull G; Schruf E; Gaubatz S
Oncotarget; 2017 Feb; 8(7):11160-11172. PubMed ID: 28061449
[TBL] [Abstract][Full Text] [Related]
24. Chelidonine suppresses migration and invasion of MDA-MB-231 cells by inhibiting formation of the integrin-linked kinase/PINCH/α-parvin complex.
Kim O; Hwangbo C; Kim J; Li DH; Min BS; Lee JH
Mol Med Rep; 2015 Aug; 12(2):2161-8. PubMed ID: 25890994
[TBL] [Abstract][Full Text] [Related]
25. DT-13 synergistically enhanced vinorelbine-mediated mitotic arrest through inhibition of FOXM1-BICD2 axis in non-small-cell lung cancer cells.
Li H; Sun L; Li H; Lv X; Semukunzi H; Li R; Yu J; Yuan S; Lin S
Cell Death Dis; 2017 May; 8(5):e2810. PubMed ID: 28542137
[TBL] [Abstract][Full Text] [Related]
26. Broussoflavonol B from
Jeong JH; Ryu JH
Molecules; 2020 May; 25(10):. PubMed ID: 32429421
[TBL] [Abstract][Full Text] [Related]
27. FoxM1 promotes breast tumorigenesis by activating PDGF-A and forming a positive feedback loop with the PDGF/AKT signaling pathway.
Yu G; Zhou A; Xue J; Huang C; Zhang X; Kang SH; Chiu WT; Tan C; Xie K; Wang J; Huang S
Oncotarget; 2015 May; 6(13):11281-94. PubMed ID: 25869208
[TBL] [Abstract][Full Text] [Related]
28. Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors.
Mancini M; De Santis S; Monaldi C; Bavaro L; Martelli M; Castagnetti F; Gugliotta G; Rosti G; Santucci MA; Martinelli G; Cavo M; Soverini S
J Exp Clin Cancer Res; 2019 May; 38(1):216. PubMed ID: 31122263
[TBL] [Abstract][Full Text] [Related]
29. Bioinformatics driven discovery of small molecule compounds that modulate the FOXM1 and PPARA pathway activities in breast cancer.
Huang S; Hu P; Lakowski TM
Pharmacogenomics J; 2023 Jul; 23(4):61-72. PubMed ID: 36424525
[TBL] [Abstract][Full Text] [Related]
30. Genistein inhibits proliferation of colon cancer cells by attenuating a negative effect of epidermal growth factor on tumor suppressor FOXO3 activity.
Qi W; Weber CR; Wasland K; Savkovic SD
BMC Cancer; 2011 Jun; 11():219. PubMed ID: 21639915
[TBL] [Abstract][Full Text] [Related]
31. Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis.
Lu M; Hartmann D; Braren R; Gupta A; Wang B; Wang Y; Mogler C; Cheng Z; Wirth T; Friess H; Kleeff J; Hüser N; Sunami Y
BMC Cancer; 2019 Sep; 19(1):887. PubMed ID: 31488102
[TBL] [Abstract][Full Text] [Related]
32. Harmine Hydrochloride Mediates the Induction of G2/M Cell Cycle Arrest in Breast Cancer Cells by Regulating the MAPKs and AKT/FOXO3a Signaling Pathways.
Ock CW; Kim GD
Molecules; 2021 Nov; 26(21):. PubMed ID: 34771123
[TBL] [Abstract][Full Text] [Related]
33. CKAP2L, transcriptionally inhibited by FOXP3, promotes breast carcinogenesis through the AKT/mTOR pathway.
Chi F; Chen L; Jin X; He G; Liu Z; Han S
Exp Cell Res; 2022 Mar; 412(2):113035. PubMed ID: 35065924
[TBL] [Abstract][Full Text] [Related]
34. MiRNA-96-5p impacts the progression of breast cancer through targeting FOXO3.
Yin Z; Wang W; Qu G; Wang L; Wang X; Pan Q
Thorac Cancer; 2020 Apr; 11(4):956-963. PubMed ID: 32100957
[TBL] [Abstract][Full Text] [Related]
35. Inactivation of the Akt/FOXM1 Signaling Pathway by Panobinostat Suppresses the Proliferation and Metastasis of Gastric Cancer Cells.
Lee NR; Kim DY; Jin H; Meng R; Chae OH; Kim SH; Park BH; Kim SM
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073071
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological activation of FOXO3 suppresses triple-negative breast cancer in vitro and in vivo.
Park SH; Chung YM; Ma J; Yang Q; Berek JS; Hu MC
Oncotarget; 2016 Jul; 7(27):42110-42125. PubMed ID: 27283899
[TBL] [Abstract][Full Text] [Related]
37. New insights into the roles of the
Mayahi S; Golalipour M; Yamchi A; Jhingan GD; Shahbazi M
Ups J Med Sci; 2019 Aug; 124(3):149-157. PubMed ID: 31294654
[No Abstract] [Full Text] [Related]
38. WHSC1 promotes wnt/β-catenin signaling in a FoxM1-dependent manner facilitating proliferation, invasion and epithelial-mesenchymal transition in breast cancer.
Zhang J; Lu J; Chen Y; Li H; Lin L
J Recept Signal Transduct Res; 2020 Oct; 40(5):410-418. PubMed ID: 32314642
[No Abstract] [Full Text] [Related]
39. Molecular mechanism of Forkhead box M1 inhibition by thiostrepton in breast cancer cells.
Kongsema M; Wongkhieo S; Khongkow M; Lam EW; Boonnoy P; Vongsangnak W; Wong-Ekkabut J
Oncol Rep; 2019 Sep; 42(3):953-962. PubMed ID: 31322278
[TBL] [Abstract][Full Text] [Related]
40. Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma.
Zhang X; Lv QL; Huang YT; Zhang LH; Zhou HH
J Exp Clin Cancer Res; 2017 Aug; 36(1):105. PubMed ID: 28784180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
